跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INDRONATE FILM-COATED TABLET 35 MG - HSA Drug Approval Details
Approvals
/
HSA
/
INDRONATE FILM-COATED TABLET 35 MG
Approved
THERAPEUTIC
INDRONATE FILM-COATED TABLET 35 MG
PHARMATHEN S.A. - GREECEPHARMATHEN INTERNATIONAL S.A. (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
Nov 14, 2013
Approval ID
b992989b5047ed67
Company
PHARMATHEN S.A. - GREECEPHARMATHEN INTERNATIONAL S.A. (GREECE)
Type
Therapeutic
Approval Details
Approval Id
b992989b5047ed67
Drug Name
INDRONATE FILM-COATED TABLET 35 MG
Product Name
INDRONATE FILM-COATED TABLET 35 MG
Approval Number
SIN14439P
Approval Date
2013-11-14
Registrant
INTEGA PTE LTD
Licence Holder
INTEGA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
M05BA07
Atc Item Name
risedronic acid
Pharma Manufacturer Name
INTEGA PTE. LTD.
Company Detail Path
/organization/intega-pte-ltd
Active Ingredients
Risedronate sodium hemipentahydrate 40.17mg equiv. to Risedronate sodium
35mg
RISEDRONATE SODIUM HEMIPENTAHYDRATE 40.17 MG EQUIV. TO RISEDRONATE SODIUM
35 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 14, 2013
Approval ID
b992989b5047ed67
Type
Therapeutic
Back to HSA Approvals